top of page
Research studies
Research studies
Patient recruitment and data collection is ongoing
2013-2017
LLDAS Validation Study
First multi-national, prospective, validation study of Lupus Low Disease Activity State (LLDAS) as a treat-to-target (T2T) endpoint, demonstrating that LLDAS attainment provides significant protection from organ damage accrual and flare in patients with systemic lupus erythematosus (SLE).
2018-2022
T2T -SLE Study
Extension and expansion of LLDAS validation study aimed to capture longer follow up data and more patient recruitment to further examine LLDAS and remission definitions.
2022-2026
Outcomes in SLE
Planned future study. Watch this space!
bottom of page